Sigilon Therapeutics Delivers Oral Presentation on SIG-001 for Hemophilia A at 2019 ASGCT Meeting May 1, 2019https://www.businesswire.com/news/home/20190501005328/en/Sigilon-Therapeutics-Delivers-Oral-Presentation-SIG-001-Hemophilia
